Acute treatment with alcohol affects calcium signaling and contraction associated with apoptosis in vas deferens of periadolescent rats.

Our purpose was to verify if alcohol causes alterations on translocation of Ca(2+) and tension induced by KCl or noradrenaline in vas deferens of periadolescent Wistar rats. A single dose of alcohol (i.p. 3.0g/kg) or saline as control, was given 4h before sacrifice. Longitudinal strips of prostatic portion were mounted in vitro for simultaneous measurements of intracellular Ca(2+) and contractions. Fluorescence and tension were measured in strips loaded with the fluorescent dye fura-2. The mean values (±S.E.M.) of fluorescence ratios (F340/380) evoked by KCl were significantly lower by about 70% after alcohol, in relation to control. It was about 50% lower when evoked by noradrenaline. In relation to tension, the respective mean values (±S.E.M.) were lower by about 60% in organs treated with KCl or by about 80% after noradrenaline. In some experiments, before noradrenaline contraction, the vas deferens was incubated with verapamil 10(-6)M for 30min. In these experiments, contractions by noradrenaline in the presence of verapamil were decreased by about 70% by alcohol. Alcohol decreases cytosolic calcium and contractility after KCl and noradrenaline, as compared with controls. In addition, alcohol promoted damage of lumen structures. Prostatic portion showed no striking morphometric change after treatment, but the number of TUNEL positive cells in muscular layer, basal lamina and lumen were increased by alcohol, indicating apoptosis, compared with controls. This investigation shows that alcohol treatment alters signaling of calcium which in turn compromises the contraction associated with a process of apoptosis of periadolescent rats.

Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens.

Galantamine, a mild acetylcholinesterase inhibitor and an allosteric ligand of nicotinic receptors, enhanced in a concentration-dependent manner the amplitude of purinergic twitch contractions of the electrically stimulated rat vas deferens (0.2 Hz, 1 ms, 60 V). Other acetylcholinesterase inhibitors also increased the twitches, showing a hierarchy of potencies of galantamine>physostigmine>tacrine>rivastigmine=donepezil. The potentiations seem to be unrelated to the ability to inhibit acetylcholinesterase, since the hierarchy of potencies to block the enzyme in vas deferens was tacrine>physostigmine>rivastigmine>donepezil>galantamine. Acetylcholine also increased the twitches; such effect was produced by a low range of concentrations of acetylcholine (10(-10)-10(-7) M). This facilitatory effect of acetylcholine on twitches was significantly potentiated by galantamine (10(-7)-10(-6) M), but not by rivastigmine or donepezil. A striking enhancement of twitches was also caused by charybdotoxin, a blocker of high-conductance Ca2+-activated K+ channels, and by 4-aminopyridine, a non-specific blocker of K+ channels; in addition, apamin, a blocker of small-conductance Ca2+-activated K+ channels, induced a lower potentiation. The antagonist mecamylamine (10(-7)-10(-6) M) reduced by 80% the potentiation by galantamine, indicating the involvement of nicotinic receptors. Therefore, it is suggested that, besides an inhibition of acetylcholinesterase, some additional mechanisms, such as blockade of Ca2+-dependent K+ channels, or activation of nicotinic receptors of nerve terminals, might be involved in twitch potentiation. These results are relevant in the context of the clinical use of galantamine to improve cognition and behaviour in patients with Alzheimer's disease.